Pacira BioSciences (PCRX) Other financing activities (2010 - 2026)

Pacira BioSciences' Other financing activities history runs 16 years deep, the most recent figure standing at $2000.0 for Q1 2026.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $2000.0 in Q1 2026; TTM through Mar 2026 was $492000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $502000.0, changed N/A from the prior year.
• Other financing activities eased to $2000.0 in Q1 2026 per PCRX's latest filing, from $490000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $11.0 million in Q1 2022 and bottomed at $2000.0 in Q1 2026.
• The 4-year median for Other financing activities is $905000.0 (2022), against an average of $3.0 million.
• Across the five-year window, Other financing activities jumped 91.41% in 2022 and tumbled 98.38% in 2023, its largest moves.
• Year by year, Other financing activities stood at $905000.0 in 2022, then tumbled by 97.13% to $26000.0 in 2023, then surged by 1784.62% to $490000.0 in 2025, then slumped by 99.59% to $2000.0 in 2026.
• Per Business Quant, the three latest PCRX Other financing activities figures stand at $2000.0 (Q1 2026), $490000.0 (Q4 2025), and $26000.0 (Q3 2023).